Akums Drugs and Pharmaceutical (AKUMS) — Cash Flow Reinvestment Rate
Akums Drugs and Pharmaceutical (AKUMS) has a Cash Flow Reinvestment Rate of 0.10x as of September 2025, reinvesting Rs1.12 Billion (capex Rs1.12 Billion ) from operating cash flow of Rs11.52 Billion. See Akums Drugs and Pharmaceutical (AKUMS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Akums Drugs and Pharmaceutical Cash Flow Reinvestment Rate (2022–2026)
Historical reinvestment intensity for Akums Drugs and Pharmaceutical across 5 annual periods. For the full cash flow conversion analysis, see Akums Drugs and Pharmaceutical (AKUMS) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Akums Drugs and Pharmaceutical (2022–2026)
Year-by-year capital reinvestment analysis for Akums Drugs and Pharmaceutical. See financial flexibility index of Akums Drugs and Pharmaceutical to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.81x | Rs9.77 Billion | Rs12.11 Billion | Rs2.31 Billion | ▼ -54.2% |
| 2025 | 1.76x | Rs8.20 Billion | Rs4.65 Billion | Rs2.72 Billion | ▲ +36.9% |
| 2024 | 1.29x | Rs6.42 Billion | Rs4.98 Billion | Rs3.11 Billion | ▼ -64.1% |
| 2023 | 3.59x | Rs6.33 Billion | Rs1.77 Billion | Rs3.29 Billion | ▼ -76.8% |
| 2022 | 15.46x | Rs4.92 Billion | Rs318.54 Million | Rs2.58 Billion | — |